The use of isotretinoin for acne – an update on optimal dosing, surveillance, and adverse effects
Top Cited Papers
- 1 August 2020
- journal article
- review article
- Published by Taylor & Francis Ltd in Expert Review of Clinical Pharmacology
- Vol. 13 (8), 885-897
- https://doi.org/10.1080/17512433.2020.1796637
Abstract
Acne is a chronic, inflammatory, and immune mediated disease of pilosebaceous unit, highly prevalent in adolescents. It involves face, trunk, and back; may leave scars and affect quality of life. Early, effective, and safe treatment is the key for disease resolution. Oral isotretinoin is the unique treatment for cure or prolonged remission for moderate and severe acne, preventing psychosocial impact and scars. It inhibits sebaceous glands activity and has anti-inflammatory and immunoregulatory properties. We performed a comprehensive literature search on PubMed database, up to March 2020, regarding oral isotretinoin for acne treatment. We synthetized data about acne pathogenesis and mechanism of action, efficacy, and safety of isotretinoin. This drug is effective, despite common, controllable, and reversible mucocutaneous side effects. Serious adverse events are rare and represent individual reactions. Teratogenicity is the most severe, requiring rigorous control. We believe that no other therapeutic option, even topicals combined to oral antibiotics accomplish same results. Recurrence after treatments other than isotretinoin is the rule, prolonging risk of scars, compromising skin appearance, and causing emotional distress in teenagers. If there is no absolute contraindication, isotretinoin should be the first line treatment for moderate to severe inflammatory acne.Keywords
This publication has 130 references indexed in Scilit:
- Alleged isotretinoin-associated inflammatory bowel disease: Disproportionate reporting by attorneys to the Food and Drug Administration Adverse Event Reporting SystemJournal of the American Academy of Dermatology, 2013
- Systemic Isotretinoin Therapy Normalizes Exaggerated TLR-2-Mediated Innate Immune Responses in Acne PatientsJournal of Investigative Dermatology, 2012
- Retinoid-Binding Proteins: Similar Protein Architectures Bind Similar Ligands via Completely Different WaysPLOS ONE, 2012
- The impact of the iPLEDGE program on isotretinoin fetal exposure in an integrated health care systemJournal of the American Academy of Dermatology, 2011
- Retinoic Acid and Affective DisordersBritish Journal of Psychology, 2011
- New developments in our understanding of acne pathogenesis and treatmentExperimental Dermatology, 2009
- Low-dose isotretinoin in the treatment of acne vulgarisJournal of the American Academy of Dermatology, 2006
- Atypical facial scarring after isotretinoin therapy in a patient with previous dermabrasionJournal of the American Academy of Dermatology, 1994
- Guidelines for optimal use of isotretinoin in acneJournal of the American Academy of Dermatology, 1992
- Prolonged Remissions of Cystic and Conglobate Acne with 13-cis-Retinoic AcidThe New England Journal of Medicine, 1979